A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HE / hepatic encephalopathy

[Related PubMed/MEDLINE]
Total Number of Papers: 1621
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HE  (>> Co-occurring Abbreviation)
Long Form:   hepatic encephalopathy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 1H NMR-Based Metabolic Signatures in the Liver and Brain in a Rat Model of Hepatic Encephalopathy. BCAAs, BDL, NMR, TCA
2020 A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients. CTP class, DM, HEFS, OHE, TIPS
2020 A novel, bedside, etiology specific prognostic model (Peds-HAV) in hepatitis A induced pediatric acute liver failure. HAV, HAV, PALF
2020 A Prognostic Strategy Based on Stage of Cirrhosis and HVPG to Improve Risk Stratification After Variceal Bleeding. HVPG
2020 A retrospective study of drug utilization and hospital readmissions among Medicare patients with hepatic encephalopathy. ---
2020 Acquired hepatocerebral degeneration and hepatic encephalopathy: one or two entities? AHD, CLD
2020 Acute Hepatic Failure and Nutrition. ALF
2020 Amelioration of thioacetamide-induced hepatic encephalopathy in rats by low-dose gamma irradiation. alpha-SMA, ALT, AST, GPx, IL-1beta, LDR, MDA, TAA, TNF-alpha
2020 Ammonia inhibits energy metabolism in astrocytes in a rapid and glutamate dehydrogenase 2-dependent manner. GDH2
10  2020 Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis. ---
11  2020 Ammonia predicts poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure. HBV-ACLF
12  2020 Ammonia-Induced Glial-Inflammaging. BBB, NF-kappaB, p38 MAPK
13  2020 Animal Naming Test - a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy. ANT, MHE, NPV, PHES, PPV
14  2020 Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis. HRS, SBP, VB
15  2020 Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosis. ---
16  2020 Astrocyte lesions in cerebral cortex and cerebellum of dogs with congenital ortosystemic shunting. CPSS
17  2020 Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema. ---
18  2020 BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats. ALB, ALT, AST, BBD, BMDMs, Iba-1, IL-6, LPS, TAA, TBA, TBIL, TNF-alpha, TP
19  2020 Brain MR Spectroscopy Markers of Encephalopathy Due to Nonalcoholic Steatohepatitis. Crhs-HE, mI, MRS, NASH
20  2020 cGMP signaling pathway in hepatic encephalopathy neuroinflammation and cognition. cGMP, NO, PKG
21  2020 Change in Patient MELD-Na and Albumin Level From the Time of Celiac Disease Diagnosis to Six Months Later After Gluten-Free Diet. CD, HCC, HLA, MELD, SBP
22  2020 Characterization of Oxidative Stress and Ammonia According to the Different Grades of Hepatic Encephalopathy. CLD, HV, MDA, OxS
23  2020 Clinical Manifestations of Hepatic Encephalopathy. ---
24  2020 Cognitive Function in Liver Transplantation. LT
25  2020 Combined PEG3350 Plus Lactulose Results in Early Resolution of Hepatic Encephalopathy and Improved 28-Day Survival in Acute-on-Chronic Liver Failure. ACLF, HESA, HR, PEG
26  2020 Comparative accuracy and precision of two commercial laboratory analyzers for the quantification of ammonia in cerebrospinal fluid. CSF
27  2020 Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis. OR, PrI, SUCRA
28  2020 Complications and Mortality in Hospitalised Patients With Decompensated Cirrhosis of Liver in a Tertiary Care Centre in Nepal. CTP, HCC, HRS, SBP, SPSS, UGI
29  2020 Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study. CEPS, PaHT
30  2020 Curcumin prevents cognitive deficits in the bile duct ligated rats. Bax, Bcl-xL, BDL, MWM, PGC-1alpha
31  2020 Difficult-to-treat ascitic fluid infection is a predictor of transplant-free survival in childhood decompensated chronic liver disease. AFI, CLD, MELD/PELD, TLC
32  2020 Disparities in Mortality and Health Care Utilization for 460,851 Hospitalized Patients with Cirrhosis and Hepatic Encephalopathy. ---
33  2020 Early Hybrid Extracorporeal Therapies in Pediatric Acute Liver Failure of Unknown Etiology. ---
34  2020 Early identification using the referral system prolonged the time to onset for hepatic encephalopathy after diagnosing severe acute liver injury. ALF, ALI, SLI
35  2020 Early, late, or no shunt embolization in patients with cirrhosis- and portosystemic shunt-related hepatic encephalopathy. ESE, LSE, PHT, PSS
36  2020 Efficacy and Safety of Ornithine Phenylacetate for Treating Overt Hepatic Encephalopathy in a Randomized Trial. OP
37  2020 Efficacy and Safety of Sodium Benzoate in The Management of Hyperammonemia in Decompensated Chronic Liver Disease of the Childhood-A Double-blind Randomized Controlled Trial. ---
38  2020 Epidemiology of Hepatic Encephalopathy. ---
39  2020 Exercise-Induced Hyperammonemia Does Not Precipitate Overt Hepatic Encephalopathy. ESLD
40  2020 Expert insights: The potential role of the gut microbiome-bile acid-brain axis in the development and progression of Alzheimer's disease and hepatic encephalopathy. AD, BA
41  2020 Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials. ACLF, ALF, ECLS, RCTs
42  2020 Factors Affecting Psychological Burden on the Informal Caregiver of Patients With Cirrhosis: Looking Beyond the Patient. BAI, BDI, PCB, PHES, ZBI
43  2020 Factors Associated with Health-Related Quality of Life in Patients with Cirrhosis: A Systematic Review. HRQoL
44  2020 Fibroblast Growth Factor-21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells. ALF, TAA
45  2020 Functional Status at Liver Transplant Waitlisting Correlates With Greater Odds of Encephalopathy, Ascites, and Spontaneous Bacterial Peritonitis. CI, FS, LT, OR, SBP
46  2020 Hepatic Encephalopathy and Nutrition Influences: A Narrative Review. ---
47  2020 Hepatic Encephalopathy: A Diagnosis for the Individual but an Experience for the Household. ---
48  2020 Hepatic encephalopathy: a rare cause of focal seizures in chronic liver disease. ---
49  2020 Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. ---
50  2020 Hepatitis C virus-associated decompensated liver cirrhosis with refractory hepatic encephalopathy successfully treated by balloon-occluded retrograde transvenous obliteration after sofosbuvir/velpatasvir. BRTO, CT, HCV, SOF/VEL, SVR
51  2020 High-mobility group protein B1: A predictive biomarker for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. HMGB1, MELD, ROC, TIPS
52  2020 Impact of non-selective ss-blockers on hepatic encephalopathy in patients with liver cirrhosis. CHE, NSBB, OHE
53  2020 Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus. ---
54  2020 Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus. ---
55  2020 Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis. AUROC, MELD-Na
56  2020 Indian National Association for the Study of LiverConsensus Statement on Acute Liver Failure (Part-2): Management of Acute Liver Failure. ALF, LT
57  2020 Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration. BRTO, CTP, IRB, PSS
58  2020 Intractable Hepatic Encephalopathy with a Large Portosystemic Shunt Successfully Treated Using Shunt-preserving Disconnection of the Portal and Systemic Circulation. SPDPS
59  2020 Laboratory Abnormalities of Hepatic Encephalopathy. ---
60  2020 Late-Onset Hepatic Failure in Children: Risk Factors that Determine the Outcome. KCC, LOHF, PELD, PO, SR
61  2020 Lessons from "real life experience" of rifaximin use in the management of recurrent hepatic encephalopathy. ---
62  2020 Liver Transplant in Acute Liver Failure - Looking Back Over 10Years. ALF, ATT, HAV, HBV, HEV, LT, YP
63  2020 Long-Term Management: Modern Measures to Prevent Readmission in Patients with Hepatic Encephalopathy. ---
64  2020 Management of Large, Spontaneous Portosystemic Shunts in Liver Transplantation: Case Report and Review of Literature. SPSS
65  2020 Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy. CENTRAL, CI, CINAHL, LILACS, MHE, MRS, NHE, OHE
66  2020 N-acetyl cysteine treatment preserves mitochondrial indices of functionality in the brain of hyperammonemic mice. NAC
67  2020 Network Pharmacology-Based Approaches of Rheum undulatum Linne and Glycyrriza uralensis Fischer Imply their Regulation of Liver Failure with Hepatic Encephalopathy in Mice. IL, MMP-9, TGF
68  2020 Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant. FMT, GABA, GF
69  2020 Nifuroxazide attenuates experimentally-induced hepatic encephalopathy and the associated hyperammonemia and cJNK/caspase-8/TRAIL activation in rats. ALF, c-JNK, TAA, TRAIL
70  2020 Nonpharmacologic Management of Hepatic Encephalopathy: An Update. ---
71  2020 Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis. ---
72  2020 Optic nerve sheath diameter in children with acute liver failure: A prospective observational pilot study. ALF, BA, ICP, INR, ONSD
73  2020 Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathy. OGC, SHR
74  2020 Outcomes After Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients 70 Years and Older. MELD-Na, TIPS
75  2020 Pathophysiology of Hepatic Encephalopathy. ---
76  2020 Pediatric Wilson Disease Presenting as Acute Liver Failure: An Individual Patient Data Meta-analysis. ALF, LT, WD
77  2020 Potential Crosstalk between Liver and Extra-liver Organs in Mouse Models of Acute Liver Injury. BDL, Con A, HRS, LR
78  2020 Potential predictors for prognosis and postpartum recovery time of acute fatty liver of pregnancy. AFLP, ALST, LF
79  2020 Predictive Power of Liver Maximum Function Capacity Test in Transjugular Intrahepatic Portosystemic Shunt Patients: A Pilot Study. LFAC, LiMAx, OHE, TIPSS
80  2020 Pro-inflammatory cytokines serve as communicating molecules between the liver and brain for hepatic encephalopathy pathogenesis and Lycium barbarum polysaccharides protection. LBP
81  2020 Propofol alone prevents worsening hepatic encephalopathy rather than midazolam alone or combined sedation after esophagogastroduodenoscopy in compensated or decompensated cirrhotic patients. EGD, NCT
82  2020 Protective effect of Lactobacillus salivarius Li01 on thioacetamide-induced acute liver injury and hyperammonaemia. BDNF, LBP, NF-kappaB, TAA
83  2020 Protective effects of synbiotic soymilk fortified with whey protein concentrate and zinc sulfate against bile duct ligated-induced hepatic encephalopathy. BDL, SM, SSM
84  2020 Psychological Burden of Hepatic Encephalopathy on Patients and Caregivers. QOL
85  2020 Quality of life, caregiver burden and mental health disorders in primary caregivers of patients with Cirrhosis. CB, PHQ, QOL, SF-36
86  2020 Recent advances in understanding and managing hepatic encephalopathy in chronic liver disease. CLD
87  2020 Reduced Incidence of Hepatic Encephalopathy and Higher Odds of Resolution Associated With Eradication of HCV Infection. aHR, DAA, HCV, MELD, SVR
88  2020 Relative Sarcopenia With Excess Adiposity Predicts Survival After Transjugular Intrahepatic Portosystemic Shunt Creation. HR, MELD, TIPS
89  2020 Retention enema with traditional Chinese medicine for hepatic encephalopathy: A protocol for a systematic review and meta-analysis. FEM, MD, REM, RR, SMD, TCM
90  2020 Retrograde Transvenous Obliteration (RTO): A New Treatment Option for Hepatic Encephalopathy. RTO
91  2020 Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients. EA, sCD163
92  2020 Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study. PHES
93  2020 Role of serine protease inhibitor, ulinastatin, in rat model of hepatic encephalopathy: aquaporin 4 molecular targeting and therapeutic implication. ALF, AQP4, BBB, TAA, ULI
94  2020 S-Adenosylmethionine Deficiency and Brain Accumulation of S-Adenosylhomocysteine in Thioacetamide-Induced Acute Liver Failure. AdoHcy, AdoMet, ALF, OS, TAA
95  2020 Sarcopenia Does Not Worsen Survival in Patients With Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites. TIPSS
96  2020 Serum 25-hydroxyvitamin D level in patients with chronic liver disease and its correlation with hepatic encephalopathy: A cross-sectional study. CLD
97  2020 Serum ammonia is a strong prognostic factor for patients with acute-on-chronic liver failure. ACLF, HBV
98  2020 Serum copeptin level is a biomarker associated with ascites retention and the formation of a portosystemic shunt in chronic liver disease. CLD, PSSs
99  2020 Serum melatonin in dogs with congenital portosystemic shunting, with and without hepatic encephalopathy. CPSS
100  2020 Serum osmolality, cerebrospinal fluid specific gravity and overt hepatic encephalopathy severity in patients with liver failure. ACLF, CSF, GCS